Acknowledgements
Not applicable.
Conflicts of interest No conflicts of interest to disclose.
DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author [AB], upon reasonable request.
ETHICAL APPROVAL In this study, no additional costs and procedures were imposed on the patient’s family members. We reported the retrograde standard treatment process of the patient. We maintained the patient’s privacy.
Key Clinical Message: Chemotherapy medications like abiraterone acetate may induce QT prolongation. Cancer patients experiencing appetite loss are vulnerable to electrolyte imbalances like hypokalemia and hypomagnesemia, enhancing the risk of fatal arrhythmias such as Torsade de Pointe.